Can a 5-Question survey improve urinary incontinence care?
NCT ID NCT07339657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to validate a Turkish version of the PRAFAB questionnaire, a short 5-question tool that measures both the physical and emotional impact of urinary incontinence in women. Researchers will enroll 63 women diagnosed with urinary incontinence to see if the questionnaire is reliable and accurate. The goal is to provide doctors with a simple, effective way to assess incontinence severity and its effect on quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emel Taşvuran Horata
RECRUITINGAfyonkarahisar, Merkez, 03030, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••